MRVI
Maravai LifeSciences Holdings, Inc.
NASDAQHealthcareBiotechnologyUS
Rating:C
Company Profile
CEO
Bernd Brust
IPO Date
2020-11-20
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Maravai LifeSciences Holdings, Inc.
CEO
Bernd Brust
IPO Date
2020-11-20
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
| 25,000 |
| $5.06 |
| 10 Jun 2026 | ORESHACK KURT | General Counsel | S-Sale | Disposed | 25,000 | $5.10 |
| 10 Jun 2026 | LUCIER GREGORY T | director | G-Gift | Disposed | 46,293 | $0.00 |
| 10 Jun 2026 | LUCIER GREGORY T | director | G-Gift | Acquired | 46,293 | $0.00 |
| 28 May 2026 | LUCIER GREGORY T | director | A-Award | Acquired | 46,293 | $0.00 |
| 28 May 2026 | MARKER LUKE JOSEPH | director | A-Award | Acquired | 46,293 | $0.00 |
| 28 May 2026 | GRAY SUSANNAH | director | A-Award | Acquired | 46,293 | $0.00 |
| 28 May 2026 | MIHAS CONSTANTINE S | director | A-Award | Acquired | 46,293 | $0.00 |
| 28 May 2026 | ECKERT R ANDREW | director | A-Award | Acquired | 46,293 | $0.00 |